Herbal products for liver diseases: a therapeutic challenge for the new millennium (Q33739196)

29 July 2017

1 reference

title

Herbal products for liver diseases: a therapeutic challenge for the new millennium (English)

1 reference

29 July 2017

Schuppan D

1

1 reference

29 July 2017

Jia JD

series ordinal

2

1 reference

29 July 2017

Brinkhaus B

series ordinal

3

1 reference

29 July 2017

Hahn EG

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

29 July 2017

1 reference

29 July 2017

30

1 reference

29 July 2017

4

1 reference

29 July 2017

1099-1104

1 reference

Traditional remedies and food supplements. A 5-year toxicological study (1991-1995).

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Hepatotoxicity of herbal remedies and mushrooms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Hepatotoxicity of herbal remedies: insights into the intricacies of plant-animal warfare and cell death

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A Depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

The pharmacokinetics of glycyrrhizin and its restorative effect on hepatic function in patients with chronic hepatitis and in chronically carbon-tetrachloride-intoxicated rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Effects of glycyrrhizin on immune-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Renin-dependency of glycyrrhizin-induced pseudoaldosteronism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Inhibition of signal-regulated protein kinases by plant-derived hydrolysable tannins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Evaluation of Phyllanthus amarus and Phyllanthus maderaspatensis as agents for postexposure prophylaxis in neonatal duck hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Identification of a protein kinase C (PKC) activator, daphnoretin, that suppresses hepatitis B virus gene expression in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Chemotherapy of Amanita phalloides poisoning with intravenous silibinin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Antioxidant activity of silybin in vivo during long-term iron overload in rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Scavenging of reactive oxygen species by silibinin dihemisuccinate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Prevention by silymarin of membrane alterations in acute CCl4 liver damage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Prevention of CCL4-induced liver cirrhosis by silymarin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Silymarin protects against paracetamol-induced lipid peroxidation and liver damage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Protection by silibinin against Amanita phalloides intoxication in beagles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Picroliv, picroside-I and kutkoside from Picrorhiza kurrooa are scavengers of superoxide anions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Perfusion with picroliv reverses biochemical changes induced in livers of rats toxicated with galactosamine or thioacetamide

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Antihepatotoxic properties of picroliv: an active fraction from rhizomes of Picrorhiza kurrooa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Preventive effects of a traditional Chinese medicine (sho-saiko-to) against oxygen toxicity and membrane damage during endotoxemia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Defense effects of a traditional Chinese medicine (sho-saiko-to) against metabolic disorders during endotoxemia; approached from the behavior of the calcium ion.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

The herbal medicine sho-saiko-to induces nitric oxide synthase in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Cell death induced by baicalein in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Herbal medicine 'Sho-saiko-to' induces tumour necrosis factor-alpha and granulocyte colony-stimulating factor in vitro in peripheral blood mononuclear cells of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Effects of the Japanese herbal medicine "Sho-saiko-to" (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Comparative study of oral and parenteral administration of sho-saiko-to (xiao-chaihu-tang) extract on D-galactosamine-induced liver injury in rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Effects of sho-saiko-to extract on fibrosis and regeneration of the liver in rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Sho-saiko-To: the right blend of traditional Oriental medicine and liver cell biology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Effect of sho-saiko-to(xiao-chai-hu-tang) on HBeAg clearance in children with chronic hepatitis B virus infection and with sustained liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300437

7 January 2021

Identifiers

DOI

10.1002/HEP.510300437

1 reference

29 July 2017

1 reference